Benchmark Capital Advisors - TRINITY BIOTECH PLC ownership

TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 42 filers reported holding TRINITY BIOTECH PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Benchmark Capital Advisors ownership history of TRINITY BIOTECH PLC
ValueSharesWeighting
Q4 2018$39,000
-50.6%
17,000
-13.8%
0.04%
-33.9%
Q3 2018$79,000
-20.2%
19,7280.0%0.06%
-21.3%
Q2 2018$99,000
-16.1%
19,728
-14.0%
0.08%
-19.4%
Q1 2018$118,000
-3.3%
22,928
-4.4%
0.09%
-2.1%
Q4 2017$122,000
-42.7%
23,982
-36.7%
0.10%
-42.4%
Q3 2017$213,000
-11.6%
37,882
-5.7%
0.16%
-13.2%
Q2 2017$241,0000.0%40,172
-0.7%
0.19%0.0%
Q1 2017$241,000
-26.7%
40,472
-14.9%
0.19%
-30.4%
Q4 2016$329,000
-74.3%
47,541
-50.9%
0.27%
-71.7%
Q3 2016$1,279,000
+23.9%
96,741
+6.3%
0.97%
+14.9%
Q2 2016$1,032,000
+6.0%
91,041
+9.0%
0.84%
-1.6%
Q1 2016$974,000
-6.7%
83,541
-5.9%
0.86%
-3.3%
Q4 2015$1,044,000
+1.5%
88,741
-1.3%
0.88%
+5.4%
Q3 2015$1,029,000
-38.3%
89,941
-2.7%
0.84%
-28.5%
Q2 2015$1,669,000
-6.2%
92,4410.0%1.17%
+0.2%
Q1 2015$1,779,000
+40.4%
92,441
+27.8%
1.17%
+37.4%
Q4 2014$1,267,000
-51.2%
72,354
-49.1%
0.85%
-5.6%
Q3 2014$2,596,000
+97.9%
142,108
+149.5%
0.90%
+10.0%
Q2 2014$1,312,000
-4.9%
56,9540.0%0.82%
-14.4%
Q1 2014$1,380,000
-3.6%
56,9540.0%0.96%
-3.4%
Q4 2013$1,432,000
+15.6%
56,9540.0%0.99%
+11.6%
Q3 2013$1,239,000
+42.6%
56,954
+10.4%
0.89%
+32.8%
Q2 2013$869,00051,6000.67%
Other shareholders
TRINITY BIOTECH PLC shareholders Q4 2018
NameSharesValueWeighting ↓
ACK Asset Management 672,100$14,625,0005.62%
GOLDMAN CAPITAL MANAGEMENT INC 312,000$6,789,0004.48%
Lyon Street Capital, LLC 407,586$8,870,047,0004.37%
GREAT POINT PARTNERS LLC 189,071$4,114,0002.85%
Adirondack Research & Management Inc. 161,507$3,514,0002.02%
Park West Asset Management LLC 483,355$10,518,0001.56%
Benchmark Capital Advisors 56,954$1,239,0000.89%
WOODMONT INVESTMENT COUNSEL LLC 76,607$1,667,0000.61%
SHEPHERD KAPLAN KROCHUK, LLC 156,000$3,394,0000.55%
HEARTLAND ADVISORS INC 1,250,364$27,208,0000.50%
View complete list of TRINITY BIOTECH PLC shareholders